PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 78 filers reported holding PLIANT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,498 | +114.0% | 6,142 | +123.7% | 0.00% | – |
| Q2 2023 | $49,754 | +32.2% | 2,746 | +94.1% | 0.00% | – |
| Q1 2023 | $37,635 | +246.4% | 1,415 | +163.5% | 0.00% | – |
| Q4 2022 | $10,866 | +262.2% | 537 | +300.7% | 0.00% | – |
| Q3 2022 | $3,000 | – | 134 | +294.1% | 0.00% | – |
| Q2 2022 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 34 | +100.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 17 | -88.7% | 0.00% | – |
| Q2 2021 | $4,000 | -66.7% | 150 | -50.0% | 0.00% | – |
| Q1 2021 | $12,000 | -45.5% | 300 | -68.4% | 0.00% | – |
| Q4 2020 | $22,000 | -18.5% | 950 | -19.1% | 0.00% | – |
| Q3 2020 | $27,000 | -53.4% | 1,175 | -34.7% | 0.00% | – |
| Q2 2020 | $58,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |